Mercer Global Advisors’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-147,857
| Closed | -$207K | – | 1953 |
|
|
2022
Q4 | $207K | Hold |
147,857
| – | – | ﹤0.01% | 1698 |
|
|
2022
Q3 | $228K | Hold |
147,857
| – | – | ﹤0.01% | 1566 |
|
|
2022
Q2 | $325K | Hold |
147,857
| – | – | ﹤0.01% | 1386 |
|
|
2022
Q1 | $367K | Sell |
147,857
-40,500
| -22% | -$101K | ﹤0.01% | 1401 |
|
|
2021
Q4 | $1.13M | Buy |
188,357
+15,000
| +9% | +$90.1K | 0.01% | 830 |
|
|
2021
Q3 | $1.16M | Buy |
173,357
+5,500
| +3% | +$36.6K | 0.01% | 793 |
|
|
2021
Q2 | $1.12M | Buy |
167,857
+10,000
| +6% | +$66.5K | 0.01% | 785 |
|
|
2021
Q1 | $1.46M | Buy |
157,857
+22,007
| +16% | +$204K | 0.01% | 642 |
|
|
2020
Q4 | $2.44M | Hold |
135,850
| – | – | 0.03% | 374 |
|
|
2020
Q3 | $1.93M | Buy |
135,850
+200
| +0.1% | +$2.84K | 0.03% | 392 |
|
|
2020
Q2 | $680K | Buy |
+135,650
| New | +$680K | 0.01% | 580 |
|